CORUS-LX System for Degenerative Disc Disease

(ILIF Trial)

This trial tests the safety and effectiveness of a new device for back surgeries in individuals with degenerative disc disease in the lower back. Researchers aim to determine if the device aids spinal fusion (joining two or more bones) while minimizing complications and reducing the need for additional treatments related to back pain. The trial compares the new device with the standard method used in these surgeries, specifically examining Supplemental Posterior Fusion with the study device versus the standard technique. Individuals experiencing persistent back or leg pain due to degenerative disc disease, who have not found relief with other treatments, might be suitable candidates for this trial. As an unphased trial, it offers patients the chance to contribute to innovative research that could enhance future treatment options.

The trial protocol does not specify if you need to stop taking your current medications. However, if you are using high-dose oral steroids or long-term opioids, you may not be eligible to participate.

Previous studies have shown that lumbar interbody fusion procedures, like the one used in this trial, are generally safe for patients with degenerative disc disease. Research indicates that these procedures, when using certain tools such as specially made spacers and devices that stabilize the spine, are effective and well-tolerated.

The CORUS-LX system, the device under study in this trial, is designed to enhance these standard procedures. Ongoing research confirms its safety and effectiveness, and initial findings suggest it does not increase the risk of major side effects.

Researchers are excited about the CORUS-LX system for treating degenerative disc disease because it offers a potentially improved technique for spinal fusion. Unlike the standard method, which relies solely on traditional tools like pedicle screws and rods, the study device aims to enhance the fusion process through its unique design. This could lead to better stabilization of the spine and possibly faster recovery times for patients. By refining the way spinal segments are fused, this new approach might improve outcomes and reduce complications, making it a promising option for those suffering from this debilitating condition.

Research has shown that lumbar interbody fusion, combined with posterior fusion, can effectively treat degenerative disc disease. Studies indicate that this surgery often successfully joins spine segments, reducing pain and improving mobility. In some cases, interbody fusion results match or surpass those of other treatments. In this trial, participants will receive either the standard supplemental posterior fusion technique or the supplemental posterior fusion with the study device, the CORUS-LX system. The CORUS-LX system aims to enhance results by potentially providing better support during healing. Early findings from other studies suggest that these fusion techniques can help manage pain and improve the quality of life for individuals with back problems.²³⁵⁶⁷